This funding opportunity encourages the creation and validation of animal models and human/animal tissue ex vivo systems that replicate neurological or neuromuscular disorder characteristics. It aims to enhance translational relevance to facilitate neurotherapeutic development, supporting early-stage drug discovery efforts without clinical trials.
Eligible applicants include state and local governments, various nonprofit organizations, for-profit organizations excluding small businesses, Native American tribal entities, small businesses, and institutions of higher education. Specific eligibility details are provided in the announcement.
